Evaluation of the in vitro activity of caspofungin against bloodstream isolates of Candida species from cancer patients: comparison of Etest and NCCLS reference methods

The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance

1996 • 779 citations

In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872)

1997 • 312 citations

In Vitro Activities of a New Lipopeptide Antifungal Agent, FK463, against a Variety of Clinically Important Fungi

2000 • 311 citations

Activity of MK-0991 (l-743,872), a new echinocandin, compared with those of LY303366 and four other antifungal agents tested against blood stream isolates of Candida spp.

1998 • 109 citations

Susceptibility of fluconazole-resistant clinical isolates of Candida spp. to echinocandin LY303366, itraconazole and amphotericin B

2000 • 65 citations

Evaluation of Etest Method for Determining Caspofungin (MK-0991) Susceptibilities of 726 Clinical Isolates of Candida Species

2001 • 63 citations

Trends in Antifungal Susceptibility among Swedish Candida Species Bloodstream Isolates from 1994 to 1998: Comparison of the E-test and the Sensititre YeastOne Colorimetric Antifungal Panel with the NCCLS M27-A Reference Method

2001 • 50 citations

Disk Diffusion Method for Determining Susceptibilities of Candida spp. to MK-0991

1999 • 43 citations

Predictors of outcome in cancer patients with candidemia

2000 • 41 citations